Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 42.06
- Piotroski Score 1.00
- Grade N/A
- Symbol (IONR)
- Company ioneer Ltd
- Price $6.53
- Changes Percentage (7.12%)
- Change $0.43
- Day Low $6.10
- Day High $6.54
- Year High $6.54
ioneer Ltd explores for and develops mineral properties in North America. It owns 100% interest in the Rhyolite Ridge lithium-boron project located in Nevada, the United States. The company was formerly known as Global Geoscience Limited and changed its name to ioneer Ltd in November 2018. ioneer Ltd was incorporated in 2001 and is based in North Sydney, Australia.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 10/31/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.06
- Trailing P/E Ratio -83.75
- Forward P/E Ratio -83.75
- P/E Growth -83.75
- Net Income $-6,391,000
Income Statement
Quarterly
Annual
Latest News of IONR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
ioneer Ltd's (ASX:INR) biggest owners are individual investors who got richer after stock soared 14% last week
16 investors collectively hold a 50% majority stake in ioneer Ltd. The top shareholder group is individual investors, benefiting from a recent 14% gain. Institutions and hedge funds also hold signific...
By Yahoo! Finance | 1 week ago -
InnovationRx: Two Industry Veterans Aim To Accelerate The Path To Personalized Care
Highlander Health, founded by former Verily execs, aims to advance personalized healthcare through investments in startups and clinical trial acceleration. Recursion Pharmaceuticals' AI-designed drug ...
By Forbes | 2 weeks ago -
InnovationRx: Investing In The $648 Billion Care Economy
GLP-1 drugs like Ozempic show promise in treating various diseases. Melinda French Gates' Pivotal Ventures focuses on empowering women in healthcare and investing in the "Care Economy." Notable invest...
By Forbes | 3 weeks ago